Xiao L - Search Results

1

Hepatic regulator of G protein signaling 14 ameliorates NAFLD through activating cAMP-AMPK signaling by targeting Giα1/3.

Wang J, Guo Y, He Y, Qin Y, Li X, Yang L, Liu K, Xiao L. Wang J, et al. Among authors: xiao l. Mol Metab. 2024 Feb;80:101882. doi: 10.1016/j.molmet.2024.101882. Epub 2024 Jan 17. Mol Metab. 2024. PMID: 38237897 Free PMC article.

2

Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.

Wang W, Zhao J, Gui W, Sun D, Dai H, Xiao L, Chu H, Du F, Zhu Q, Schnabl B, Huang K, Yang L, Hou X. Wang W, et al. Among authors: xiao l. Br J Pharmacol. 2018 Feb;175(3):469-484. doi: 10.1111/bph.14095. Epub 2018 Jan 3. Br J Pharmacol. 2018. PMID: 29139555 Free PMC article.

3

Creg in Hepatocytes Ameliorates Liver Ischemia/Reperfusion Injury in a TAK1-Dependent Manner in Mice.

Yang L, Wang W, Wang X, Zhao J, Xiao L, Gui W, Fan H, Xia J, Li Z, Yan J, Alasbahi A, Zhu Q, Hou X. Yang L, et al. Among authors: xiao l. Hepatology. 2019 Jan;69(1):294-313. doi: 10.1002/hep.30203. Hepatology. 2019. PMID: 30076625

4

Prognostic significance of CXCR7 in cancer patients: a meta-analysis.

Fan H, Wang W, Yan J, Xiao L, Yang L. Fan H, et al. Among authors: xiao l. Cancer Cell Int. 2018 Dec 19;18:212. doi: 10.1186/s12935-018-0702-0. eCollection 2018. Cancer Cell Int. 2018. PMID: 30574021 Free PMC article.

5

Nonalcoholic fatty liver disease, a potential risk factor of non-specific ST-T segment changes: data from a cross-sectional study.

Xiao L, Bai T, Zeng J, Yang R, Yang L. Xiao L, et al. PeerJ. 2020 May 13;8:e9090. doi: 10.7717/peerj.9090. eCollection 2020. PeerJ. 2020. PMID: 32440372 Free PMC article.

6

Liver damage at admission is an independent prognostic factor for COVID-19.

Chen LY, Chu HK, Bai T, Tu SJ, Wei Y, Li ZL, Hu LL, Zhu R, Zhang L, Han CQ, Xiao L, He Q, Song J, Liu WH, Zhu QJ, Chen H, Yang L, Hou XH. Chen LY, et al. Among authors: xiao l. J Dig Dis. 2020 Sep;21(9):512-518. doi: 10.1111/1751-2980.12925. J Dig Dis. 2020. PMID: 32713118

7

Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19.

Chu H, Bai T, Chen L, Hu L, Xiao L, Yao L, Zhu R, Niu X, Li Z, Zhang L, Han C, Song S, He Q, Zhao Y, Zhu Q, Chen H, Schnabl B, Yang L, Hou X. Chu H, et al. Among authors: xiao l. Front Med (Lausanne). 2020 Oct 20;7:584342. doi: 10.3389/fmed.2020.584342. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33195339 Free PMC article.

8

Corrigendum: Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19.

Chu H, Bai T, Chen L, Hu L, Xiao L, Yao L, Zhu R, Niu X, Li Z, Zhang L, Han C, Song S, He Q, Zhao Y, Zhu Q, Chen H, Schnabl B, Yang L, Hou X. Chu H, et al. Among authors: xiao l. Front Med (Lausanne). 2021 Sep 16;8:764493. doi: 10.3389/fmed.2021.764493. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34604269 Free PMC article.

9

Hepatocyte TGF-β Signaling Inhibiting WAT Browning to Promote NAFLD and Obesity Is Associated With Let-7b-5p.

Zhao J, Hu L, Gui W, Xiao L, Wang W, Xia J, Fan H, Li Z, Zhu Q, Hou X, Chu H, Seki E, Yang L. Zhao J, et al. Among authors: xiao l. Hepatol Commun. 2022 Jun;6(6):1301-1321. doi: 10.1002/hep4.1892. Epub 2022 Jan 11. Hepatol Commun. 2022. PMID: 35018737 Free PMC article.

10

Retrorsine Cooperates with Gut Microbiota to Promote Hepatic Sinusoidal Obstruction Syndrome by Disrupting the Gut Barrier.

Xiao L, Hu L, Chu H, Chen L, Yan J, Wang W, Yang X, Zhu Q, Du F, Song Y, Chen P, Hou X, Yang L. Xiao L, et al. J Clin Transl Hepatol. 2022 Dec 28;10(6):1086-1098. doi: 10.14218/JCTH.2021.00398. Epub 2022 Mar 11. J Clin Transl Hepatol. 2022. PMID: 36381109 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,895 results

Search Page

Filters